Albany, NY -- (SBWIRE) -- 03/25/2019 -- Point-of-care testing can be defined as a fast, specific medical diagnostic testing of bodily fluids at the bedside. Control of anticoagulation therapy has been plagued with a relatively high indigence of adverse reactions which result in hemorrhage or thrombosis. This adverse reaction is due to complexity of anticoagulation theory or due to drug's adverse reaction which leads to various blood disorders. Therefore, a number of tests are performed to determine the factors involved in blood clotting to treat coagulating disorder factors. Presently, medical device companies develop various technologies for POC coagulating testing which provides accurate and short time results.
Read Report Overview: https://www.transparencymarketresearch.com/point-of-care-coagulation-testing-market.html
Increase in the number of surgeries such as caesarean, spinal osteomyelitis, and coronary revascularization drive demand for point-of-care coagulation testing before surgery. Moreover, conventional laboratory tests have long turnaround times, whereas point-of-care coagulation testing can provide results within minutes. This factor also propels the global market.
Based on test type, the global point-of-care coagulation testing market can be classified into prothrombin time/international normalized ratio (PT-INR) testing, bleeding time testing, fibrinogen level testing, and others. The prothrombin time/international normalized ratio testing segment is projected to account for significant share of the point-of-care coagulation testing market in the near future. This is due to increase in the number of major surgeries across the globe. PT-INR test is quite useful in diagnosing bleeding disorders in patients. Hence, doctors prefer to do the test before a major surgery to make sure that blood is clotting normally or not. In terms of end-user, the market can be categorized into hospitals, clinics, and others. The hospitals segment is expected to grow at a rapid pace during the forecast period because a large number of patients prefer to visit hospitals, as these are well-equipped with all types of equipment to perform different tests. Moreover, most of the major surgeries are performed in hospitals.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56190
In terms of region, the global point-of-care coagulation testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global point-of-care coagulation testing market in 2017. The region is projected to account for significant share of the global point-of-care coagulation testing market during the forecast period, owing to high adoption of point-of-care testing devices in hospitals due to advantages such as real time visual displays of clot evolution at the point-of-care for help in treatment purpose. Increase in demand for reducing inappropriate transfusion and rise in preference for point-of-care coagulation testing which provides accurate and fast results among patients are expected to drive the point-of-care coagulation testing market in Europe. Surge in the rate of hospitalization for different surgeries which need PT-INR testing and rise in awareness about the different advantages of point-of-care coagulation testing are anticipated to propel the point-of-care coagulation testing market in Asia Pacific. Growth of the medical device industry and increase in the number of hospitals are factors likely to augment the point-of-care coagulation testing market in Middle East & Africa.
Major players operating in the global point-of-care coagulation testing market include Abbott, F. Hoffmann-La Roche, Danaher Corporation, Medtronic, Siemens Healthineers, and International Technidyne Corporation.
Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=56190
About Transparency Market Research
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/